Stephen Ralph is Global Marketing and New Product Development at W. L. Gore & Associates, where he leads commercialization, innovation, and product strategy for advanced cardiovascular and cardiac surgery technologies. With more than 40 years of experience spanning medical devices, healthcare innovation, cardiovascular medicine, and global product commercialization, he has played a pivotal role in developing transformative technologies that have improved patient outcomes worldwide. Throughout his career, Stephen has held senior leadership positions at W. L. Gore & Associates, Alere (now Abbott), CardioMEMS (now Abbott), Medtronic, GE Healthcare, and Baxter Healthcare. His contributions include advancing cardiac resynchronization therapy (CRT), pioneering implantable wireless hemodynamic monitoring for heart failure management, and leading the development and commercialization of innovative cardiovascular and surgical technologies. He is recognized for his expertise in identifying unmet clinical needs and translating them into successful product strategies that bridge clinical, regulatory, and commercial requirements. A named inventor on multiple patents, Stephen combines deep clinical insight with business leadership. He holds an MBA from York St John University, an MSc in Business Management from the University of South Wales, and has completed executive education in medical innovation at Stanford University. Beyond his corporate leadership, he serves as an advisor, mentor, judge, and panelist for organizations including MedTech Innovator, BioTools Innovator, and the UCLA Biodesign Innovation Council. His work remains focused on advancing breakthrough medical technologies, particularly solutions that improve outcomes for adult and pediatric cardiac surgery patients.